Article

Could Gout Vanish Rather Than Increasing?

Could gout go the way of smallpox? It might, if only everyone would follow the guidelines available for management, says an editorial.

Gout: a disease of the past, the present, but not the future?Lancet, Jan. 25, 2014

Gout “has the potential to be a disorder of the past,” says this editorial, if general practitioners "start treating all patients with gout according to current guidelines and advising on diet and lifestyle,” adding that the 2012 American College of Rheumatology guidelines "are a good basis.”

The editorial draws attention to a newly published study in the Annals of the Rheumatic Diseases that points out increases in goutin the UK, US, and New Zealand, possibly because of increases in hypertension, obesity, type 2 diabetes, and chronic kidney disease.

Most people with gout in the U.K. were not advised about the disease or given treatment, that study found. This is despite a “renaissance” of insights into the underlying biology and new drugs to affect many of its mechanisms, notes the editorial in Lancet.

A questionnaire-based study about gout treatment practices among primary care providers in the US, published last April in Rheumatology, found that only about half were treating gout as recommended by US and European guidelines.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.